<DOC>
	<DOC>NCT00362271</DOC>
	<brief_summary>The purpose of this clinical research study is to learn whether aripiprazole has effect on the steady-state pharmacokinetics of venlafaxine in healthy subjects. The safety and tolerability of aripiprazole and venlafaxine co-administration will also be studied.</brief_summary>
	<brief_title>Aripiprazole and Effexor XR Drug Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Healthy male and female subjects, ages 18 to 45 (WOCBP) must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to 4 weeks after the study in such a manner that the risk of pregnancy is minimized. Body Mass Index (BMI) of 18 to 33 kg/m2, inclusive. Subjects with a decrease in SBP of &gt;=20 mm Hg and increase in HR of &gt;=20 bpm after 2 minutes standing vs. 2 minutes supine at screening or with frank orthostatic hypotension at screening. Supine BP of 90/50 mm Hg or lower at screening SBP &gt;=140 mm Hg or DBP &gt;=90 mm Hg at screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>